Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete

NEXT STORY
Innate Pharma files registration statement for proposed initial public offering in the United States
PREV STORY
XBiotech Announces Granting of Canadian Patent for Treatment of Dermatological Pathologies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Dr. Deborah Dunsire bliver ny administrerende direktør for Lundbeck

Valby, Denmark, 2. juli 2018 - H. Lundbeck A/S (Lundbeck) har i dag offentliggjort, ...

author_avatar
NASDAQ Market News

Inovio Pharmaceuticals Appoints Dr. Ami Shah Brown As Vice President Regulatory Affairs

PLYMOUTH MEETING, Pa., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

author_avatar
NASDAQ Market News

ASLAN Pharmaceuticals to Present at HC Wainwright 20th Annual Global Investment Conference

SINGAPORE, Sept. 04, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News